CC Murphy, CAM Burnett, PGD Spry, DC … - British Journal of …, 2003 - bjo.bmj.com Results: Mean intraocular pressure (IOP) decreased significantly from 40.7 mm Hg (SD 13.7) before
cyclodiode therapy to 17.7 mm Hg (SD 10.9) post-treatment, a reduction of 52.6% (p = 0.0001).
Following cyclodiode, 89% of ... Cited by 18 - Related articles - BL Direct - All 8 versions
E Ansari, J Gandhewar - Eye, 2006 - nature.com Transscleral diode laser cyclophotocoagulation (TSCP) is widely accepted in the treatment of
refractory glaucoma especially in eyes with poor vision. However, until recently, there has been a
reluctance to extend its use to ... Cited by 10 - Related articles - BL Direct - All 4 versions
V Pucci, F Tappainer, S Borin, R Bellucci - Ophthalmologica, 2003 - content.karger.com Background and Objective: Patients affected by glaucoma refractory to medical or surgical treatment
are difficult to treat. The aim of this study was to evaluate the long-term effect of contact
transscleral diode laser ... Cited by 10 - Related articles - BL Direct - All 5 versions
MJW FRACO - Clinical & experimental ophthalmology - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 20 - Related articles - BL Direct - All 4 versions
SHL CHANG, YC CHEN, CY LI, SC WU - Canadian journal of ophthalmology, 2004 - cat.inist.fr Contexte: La cyclophotocoagulation transsclérale au laser diode a donné des résultats prometteurs
pour le traitement du glaucome réfractaire. Le traitement utilisant un degré moindre d'énergie
par impulsion et globalement moins ... Cited by 10 - Related articles - BL Direct - All 2 versions
A Mistlberger, JM Liebmann, H Tschiderer, R … - Journal of …, 2001 - journals.lww.com Supported in part by the New York Glaucoma Research Institute, New York, New York. Presented in part
at the meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale,
Florida, May 1998. Cited by 19 - Related articles - BL Direct - All 2 versions
JSM Lai, CCY Tham, JCH Chan, DSC Lam - Journal of glaucoma, 2005 - journals.lww.com From the *Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong;
†United Christian Hospital, Kowloon, Hong Kong SAR, Peoples' Republic of China; ‡Hong Kong Eye
Hospital, Kowloon, Hong Kong SAR, ... Cited by 20 - Related articles - All 9 versions
ME Iliev, S Gerber - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: Mean follow-up (FU) was 30.1 (SD 16.7) months. Mean number of treatment sessions per eye
was 1.54, 89% of the eyes having 1 or 2 sessions; overall re-treatment rate: 38.9%. Mean total laser
energy delivered per eye: 133.9 ... Cited by 6 - Related articles - BL Direct - All 3 versions
M Grueb, JM Rohrbach, KU Bartz-Schmidt, T … - Graefe's Archive for …, 2006 - Springer Abstract Background: Transscleral diode laser cyclophotocoagulation (TDLC) has been used
successfully in the treatment of refractive glaucoma. However, little is known about TDLC as a
primary or secondary surgical ... Cited by 8 - Related articles - BL Direct - All 3 versions
R Mehta, G Puthuran, R Krishnadas, R Mahalakshmi - Asian J Ophthalmol, 2006 - seagig.org Introduction Transscleral diode laser cyclophotocoagulation (cyclodiode) has been established as a
relatively safe and effective intervention for glaucoma resistant to conventional management.1,2 The
procedure has become increasingly ... Cited by 1 - Related articles - All 3 versions
